factual

Flibanserin Harm Study Used Mostly Men

Flibanserin, a drug for low female libido, was initially rejected by the FDA for tiny benefits and notable harms (including poor reaction with alcohol) but approved after pressure from a patient advocacy group ('Even the Score') that turned out to be funded by the drug's maker; tellingly, the study of its harmful side effects had a majority of male subjects.

factualpending

Speaker

Jacob Stegenga

Evidence Quote

“Turns out that that patient advocacy group was funded by the company that made the drug... There was a study of the harmful side-effects of flibanserin. And in that study, the majority of subjects were men.”

Source

Jacob Stegenga on Medical Nihilism— EconTalk
Created: 6/13/2026, 12:09:58 AM

Your notes

Loading notes...